InMed Pharmaceuticals Inc. (OTCMKTS:IMLFF – Get Free Report)’s stock price dropped 3.6% during trading on Wednesday . The stock traded as low as $4.77 and last traded at $4.79. Approximately 20,203 shares changed hands during mid-day trading, an increase of 78% from the average daily volume of 11,369 shares. The stock had previously closed at $4.97.
InMed Pharmaceuticals Trading Down 3.6 %
The stock has a fifty day simple moving average of $3.82 and a 200-day simple moving average of $1.50.
InMed Pharmaceuticals Company Profile
InMed Pharmaceuticals Inc, a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of orofacial pain.
See Also
- Five stocks we like better than InMed Pharmaceuticals
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- How to Buy Cheap Stocks Step by Step
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Want to Profit on the Downtrend? Downtrends, Explained.
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for InMed Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMed Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
